Mechanisms underlying neural cell death in neurodegenerative diseases: Alterations of a developmentally-mediated cellular rheostat

Trends in Neurosciences

Volumn 23, Issue 12, 2000, Pages 599-605

  Mehler, Mark F ^a   Gokhan, Solen ^a  

^a New York State Office of Mental Retardation and Developmental Disabilities   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DAMAGE; DEGENERATIVE DISEASE; DEVELOPMENTAL DISORDER; GENE EXPRESSION; GENE MUTATION; HOMEOSTASIS; HUMAN; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE REGENERATION; NEUROPROTECTION; PRIORITY JOURNAL; REVIEW;

EID: 0034537209     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(00)01705-7     Document Type: Note

References (65)

1. Molecular basis of the neurodegenerative disorders
2. Expression of presenilin 1 in nervous system during rat development
3. Expression of normal and mutant huntingtin in the developing brain
4. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue
5. Cellular expression and proteolytic processing of presenilin proteins is developmentally regulated during neuronal differentiation
6. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion
7. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
8. Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly
9. Wild-type huntingtin protects from apoptosis upstream of caspase-3
10. Huntingtin: A single bait hooks many species
11. Binding partners of Alzheimer's disease proteins: Are they physiologically relevant?
12. Presenilin 1 facilitates the constitutive turnover of beta-catenin: Differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin-signaling pathway
13. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
14. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: Involvement of perturbed calcium homeostasis
15. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
16. A one-hit model of cell death in inherited neuronal degenerations
17. At the nexus between pattern formation and cell-type specification: The generation of individual neuroblast fates in the Drosophila embryonic central nervous system
18. Frataxin shows developmentally regulated tissue-specific expression in the mouse embryo
19. Abundant expression and cytoplasmic aggregations of α-1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6
20. A mouse model for spinal muscular atrophy
21. Mutant mice with scrambled brains: Understanding the signaling pathways that control cell positioning in the CNS
22. Neuronal migration disorders: From genetic diseases to developmental mechanisms
23. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: Isoform-specific effects on neurodegeneration
24. Combinatorial codes in signaling and synergy: Lessons from pituitary development
25. Mutations resulting in transient and localized degeneration in the developing zebrafish brain
26. Misexpression of a bHLH gene, cNSCL1, results in abnormal brain development
27. Positional apoptosis during vertebrate CNS development in the absence of endogenous retinoids
28. Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB
29. Presenilin is required for activity and nuclear access of notch in Drosophila
30. Roles of Wnt proteins in neural development and maintenance
31. Presenilins interact with armadillo proteins including neural-specific plakolphilin-related protein and beta-catenin
32. Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex
33. Notch signaling: Cell fate control and signal integration in development
34. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice
35. Cellular survival: A play in three Akts
36. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells
37. The localization and interactions of huntingtin
38. Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice
39. Disassembly of nuclear inclusions in the dividing cell - A novel insight into neurodegeneration
40. Mutant huntingtin forms in vivo complexes with distinct context-dependent conformations of the polyglutamine segment
41. Isolation and characterization of the rat huntingtin promoter
42. Presenilin 1 protein directly interacts with Bcl-2
43. Interaction of Alzheimer's presenilin-1 and presenilin-2 with bcl-X (L). A potential role in modulating the threshold of cell death
44. Skeletal and CNS defects in presenilin-1-deficient mice
45. Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid β-peptide toxicity: Central roles of superoxide production and caspase activation
46. Effects of PS1 deficiency on membrane protein trafficking in neurons
47. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response
48. Wingless and notch regulate cell-cycle arrest in the developing Drosophila wing
49. The cell division cycle and the pathophysiology of Alzheimer's disease
50. A myristolated calcium-binding protein that preferentially interacts with Alzheimer's disease presenilin 2 protein
51. Fluorescent light-induced chromatid breaks distinguish Alzheimer disease cells from normal cells in tissue culture
52. Linking DNA damage and neurodegeneration
53. Secondary abnormalities of mitochondrial DNA associated with neurodegeneration
54. Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways
55. Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin
56. CREB-binding protein sequestration by expanded polyglutamine
57. α-Synuclein shares physical and functional homology with 14-3-3 proteins
58. The synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease
59. Developmental expression of α-synuclein in rat hippocampus and cerebral cortex
60. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
61. Ubiquitin and its role in neuro-degeneration
62. The ubiquitin pathway in Parkinson's disease
63. The deubiquitinating enzyme Fam interacts with and stabilizes β-catenin
64. Undifferentiated cells in the developing Drosophila eye influence facet assembly and require the Fat facets ubiquitin-specific protease
65. Developmental expression and regulation of neurodegenerative disease proteins in embryonic stem cells, neural progenitor species, and differentiated neurons and glia